Tuesday, March 12, 2013

The latest on C. diff

It seems we're not making a tremendous amount of progress in wiping out this super-bug:


1 comment:

Anonymous said...

– 1 of 1
Anonymous said...
Human Thyroid Study

Thyroglobulin levels in some patients returned entirely to normal in study http://tinyurl.com/aav8jjz Article http://ht.ly/iw3hm

"The potential of anatabine citrate, the active ingredient in Anatabloc, has been validated by the completed human thyroiditis study performed by a number of noted endocrinologists from Johns Hopkins Medical School, chiefly the director of endocrinology and metabolism, Dr. Paul W. Ladenson.

The results of this study are simply stunning. Because this is a nutraceutical, however, Star cannot use words like “cure” or “treat.” If they did use that language, the legal status of the compound would then be shifted to “drug” status and would require full regulatory approval. This would be a tragedy for human health, as the actual announced preliminary results of the study are historic, providing the only hope for preventing or reversing thyroiditis and other autoimmune-related diseases.

In other words, all the scientific markers of thyroiditis were decreasing and continuing to improve over time, even at low doses. This is simply astonishing. Nothing has ever produced these results before, and anybody at risk for thyroiditis would be crazy at this point, given two years of toxicity data from Harvard, not to use Anatabloc."


"Anecdotal, nonetheless worthy of note; a Big Pharma Ph.D. scientist who specializes in ulcerative colitis research and is out in front of the anatabine science emailed me commenting on the press release. He said. "If I had ulcerative colitis or Crohn's, I would be popping this stuff like M&M's." The "stuff" he mentions is Anatabloc."

April 4, 2013 at 9:10 PM